CLOSE X
GO

SBI Healthcare Opp Fund-Reg(G)

very highequitypharma & health care
420.24 -2.22(-0.53%) NAV as on 29 Apr 2025
2.09 % 1 M
20.63 % 1 Y
23.83 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.94

As on 31 Mar, 2025
age-icon Age :

25 yrs 9 m

Since 14 07 ,1999
exit_load Exit Load :

0.5%

aum AUM :

3,610.51 Crs

lock_in Lock-in :

0.50% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.23

Min_Investment Min. Investment :

SIP 500 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Tanmaya Desai,Pradeep Kesavan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2025
Debt 0.08 %
Others 2.96 %
Equity 96.96 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.45 %
Max Healthcare Institute Ltd.6.68 %
Divi's Laboratories Ltd.6.00 %
Cipla Ltd.4.79 %
Lupin Ltd.4.72 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs61.62
Hospital & Healthcare Services24.37
Medical Equipment/Supplies/Accessories3.36
Chemicals3.22
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)252.90286.90281.32444.33532.43
Net Assets(Rs Crores) (as on 31-Mar-2025) 1563.95 1778.29 1589.27 2626.34 3610.51
Scheme Returns(%)(Absolute)73.5112.48-1.8658.8818.76
B'mark Returns(%)(Absolute)NANANANANA
Category Rank39/7548/7557/7614/904/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

SBI Healthcare Opp Fund-Reg(G)Very HighEquity420.24-2.22(-0.53%)NAV As on 29 Apr, 202514-Jul-1999Inception Date3,610.51AUM In Cr.20.63%1Y23.83%3Y24.41%5Y16.32%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.27-0.28(-0.75%)NAV As on 29 Apr, 202513-Jul-2018Inception Date4,914.64AUM In Cr.20.77%1Y24.16%3Y25.01%5Y21.35%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.30-0.28(-0.93%)NAV As on 29 Apr, 202528-Dec-2015Inception Date1,183.65AUM In Cr.15.75%1Y20.26%3Y21.78%5Y12.19%Since Inception
Nippon India Pharma Fund(G)Very HighEquity496.60-3.09(-0.62%)NAV As on 29 Apr, 202505-Jun-2004Inception Date8,080.97AUM In Cr.15.44%1Y20.01%3Y22.50%5Y20.53%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors